Journey Medical signals positive EBITDA for remainder of 2026 as it plans to add up to 5 sales professionals
Journey Medical Corporation Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.31
+22% in 1d after detection
Post-detection moves
1h
—
1d
+22%
3d
+20%
7d
+15%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS